Nausea, gastroparesis, and aerophagia

Journal of Clinical Gastroenterology

Volumn 39, Issue 5 SUPPL. 3, 2005, Pages

  Hasler, William L ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b Box 0362 ^*  (United States)

Author keywords

Behavioral therapy; Botulinum toxin; Central nervous system; Gastric emptying; Neurostimulation

Indexed keywords

AMITRIPTYLINE; ANTIEMETIC AGENT; APREPITANT; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CORTICOSTEROID; DIMENHYDRINATE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; ERYTHROMYCIN; GRANISETRON; MECLOZINE; METOCLOPRAMIDE; NEUROKININ 1 RECEPTOR ANTAGONIST; NORTRIPTYLINE; OCTREOTIDE; ONDANSETRON; PROCHLORPERAZINE; SCOPOLAMINE; SUMATRIPTAN; TEGASEROD; TETRAHYDROCANNABINOL; ANTIPARKINSON AGENT;

AEROPHAGIA; ANXIETY; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DRUG MECHANISM; DYSTONIA; ERUCTATION; GALACTORRHEA; GASTROINTESTINAL TRACT SCINTISCANNING; HUMAN; HYPERPROLACTINEMIA; IMPLANTATION; MIGRAINE; NAUSEA AND VOMITING; NERVE STIMULATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SIDE EFFECT; STOMACH EMPTYING; STOMACH MOTILITY; STOMACH PARESIS; TARDIVE DYSKINESIA; DIFFERENTIAL DIAGNOSIS; METHODOLOGY; NAUSEA; REVIEW;

AEROPHAGY; ANTI-DYSKINESIA AGENTS; ANTIEMETICS; BEHAVIOR THERAPY; BOTULINUM TOXINS; DIAGNOSIS, DIFFERENTIAL; GASTROPARESIS; HUMANS; NAUSEA;

EID: 23244464977     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000156111.69232.f2     Document Type: Conference Paper

References (41)

1. Li BU, Murray RD, Heitlinger LA, et al. Is cyclic vomiting syndrome related to migraine? J Pediatr. 1999;134:567-572.
2. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis - clinical characteristics and long-term outcomes. Am J Gastroenterol. 1997;92:1501-1504.
3. Mearin F, Camilleri M, Malagelada J-R. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology. 1986;90:1919-1925.
4. Sarnelli G, Caenepeel P, Geypens B, et al. Symptoms associated with impaired gastric emptying of solids and liquids in functional dyspepsia. Am J Gastroenterol. 2003;98:783-788.
5. Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med. 1991;18:229-234.
6. Jones KL, Horowitz M, Berry M, et al. Blood glucose concentrations influences postprandial fullness in IDDM. Diabetes Care. 1997;29:1141-1146.
7. Parkman HP, Miller MA, Trate D, et al. Electrogastrography and gastric emptying scintigraphy are complementary for assessment of dyspepsia. J Clin Gastroenterol. 1997;24:214-219.
8. Samsom M, Salet GA, Roelofs JM, et al. Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci. 1995;40:2037-2042.
9. Fraser RJ, Horowitz M, Maddox AF, et al. Hyperglycemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:675-680.
10. Kamolz T, Bammer T, Granderath FA, et al. Comorbidity of aerophagia in GERD patients: outcome of laparoscopic antireflux surgery. Scand J Gastroenterol. 2002;37:138-143.
11. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569-1580.
12. Hoogerwerf WA, Pasricha PJ, Kalloo AN, et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol. 1999;94:1029-1033.
13. Lee HR, Lennon VA, Camilleri M, et al. Paraneoplastic gastrointestinal motor dysfunction: clinical and laboratory characteristics. Am J Gastroenterol. 2001;96:373-379.
14. Tougas GH, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462.
15. 13C-octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology. 1997;112:1155-1162.
16. Kuiken SD, Samsom M, Camilleri M, et al. Development of a test to measure gastric accommodation in humans. Am J Physiol. 1999;277:G1217-G1221.
17. Galil MA, Critchley M, Mackie CR. Isotope gastric emptying tests in clinical practice: expectation, outcome, and utility. Gut. 1993;34:916-919.
18. Parkman HP, Hasler WL, Barnett JL, et al. Electrogastrography: a document prepared by the gastric section of the American Motility Society Clinical GI Motility Testing Task Force. Neurogastroenterol Motil. 2003;15:488-497.
19. Soffer E, Thongsawat S. Clinical value of duodenojejunal manometry: its usefulness in diagnosis and management of patients with gastrointestinal symptoms. Dig Dis Sci. 1996;41:859-863.
20. Prakash C, Lustman CJ, Freedland KE, et al. Tricyclic antidepressants for functional nausea and vomiting: clinical outcome in 37 patients. Dig Dis Sci. 1998;43:1951-1956.
21. Benson JM, Zorn SL, Book LS. Sumatriptan in the treatment of cyclic vomiting. Ann Pharmacother. 1995;29:997-999.
22. Navari RM, Reinhardt RR, Gralla RJ, et al. Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group. N Engl J Med. 1999;340:190-195.
23. 1 antagonist. Drugs Future. 2002;27:211-222.
24. McCallum RW, Valenzuela G, Polepalle S, et al. Subcutaneous metoclopramide in the treatment of symptomatic gastroparesis: clinical efficacy and pharmacokinetics. J Pharmacol Exp Ther. 1991;258:136-142.
25. Fang J, McCallum R, DiBase J, et al. Effect of mitemcinal fumarate (GM-611) on gastric emptying in patients with idiopathic or diabetic gastroparesis [Abstract]. Gastroenterology. 2004;126:T1387.
26. Tougas G, Chen Y, Luo D, et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms ([Abstract]. Gastroenterology. 2003;124:A54.
27. Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med. 1991;325:1461-1467.
28. Abouezzi ZE, Melvin WS, Ellison EC, et al. Functional and symptomatic improvement in patients with diabetic gastroparesis following pyloroplasty [Abstract]. Gastroenterology. 1998;114:A1374.
29. Miller LS, Szych GA, Kantor SB, et al. Treatment of idiopathic gastroparesis with injection of botulinum toxin into the pyloric sphincter muscle. Am J Gastroenterol. 2002;97:1653-1660.
30. Lacy BE, Zayat EN, Crowell MD, et al. Botulinum toxin for the treatment of gastroparesis: a preliminary report. Am J Gastroenterol. 2002;97:1548-1552.
31. McCallum RW, Chen JD, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology. 1998;114:456-461.
32. Abell TL, Van Cutsem E, Abrahamsson H, et al. Gastric electrical stimulation in intractable symptomatic gastroparesis. Digestion. 2002;66:204-212.
33. Forster J, Sarosiek I, Lin Z, et al. Further experience with gastric stimulation to treat drug refractory gastroparesis. Am J Surg. 2003;186:690-695.
34. Abell T, Lou J, Tabbaa M, et al. Gastric electrical stimulation for gastroparesis improves nutritional parameters at short, intermediate, and long-term follow-up. JPEN. 2003;27:277-281.
35. Abell T, McCallum R, Hocking M, et al. Gastric electrical stimulation for medically refractory gastroparesis. Gastroenterology. 2003;125:421-428.
36. Liu J, Qiao X, Chen JD. Vagal afferent is involved in short-pulse gastric electrical stimulation in rats. Dig Dis Sci. 2004;49:729-737.
37. Xing JH, Brody F, Brodsky J, et al. Gastric electrical stimulation at proximal stomach induces gastric relaxation in dogs. Neurogastroenterol Motil. 2003;15:15-23.
38. Tack J, Coulie B, Van Cutsem E, et al. The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis [Abstract]. Gastroenterology. 1999;116:G4733.
39. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol. 1996;91:2174-2178.
40. Eckhauser RE, Conrad M, Knol JA, et al. Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome. Am Surg. 1998;64:711-717.
41. Rashed H, Cutts T, Abell T, et al. Predictors of response to a behavioral treatment in patients with chronic gastric motility disorders. Dig Dis Sci. 2002;47:1020-1026.